Intra-Cellular Therapies Inc. buy TD Cowen
Start price
18.04.24
/
50%
€68.50
Target price
18.04.25
€84.35
Performance (%)
-2.19%
Price
23.08.24
€67.00
Summary
This prediction is currently active. With a performance of -2.19%, the BUY prediction for Intra-Cellular Therapies Inc. by TD_Cowen is down slightly. This prediction currently runs until 18.04.25. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | -2.899% | -2.899% |
iShares Core DAX® | 1.665% | 1.692% |
iShares Nasdaq 100 | -0.475% | 1.483% |
iShares Nikkei 225® | 2.620% | 4.475% |
iShares S&P 500 | -0.091% | 1.099% |
Comments by TD_Cowen for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at TD Cowen from $80.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by TD_Cowen for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€55.30
11.12.23
11.12.23
€69.65
11.12.24
11.12.24
21.16%
23.08.24
23.08.24